Large-scale testing (Phase 3)Study completedNCT00985166What this trial is testingProQuad in Healthy 4 to 6 Year Old Children (V221-014)Who this might be right forMeaslesMumpsRubella+1 more Merck Sharp & Dohme LLC 801
Post-approval studies (Phase 4)Study completedNCT00388440What this trial is testingAssess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.Who this might be right forRubellaMumpsMeasles GlaxoSmithKline 150
Large-scale testing (Phase 3)Study completedNCT00384397What this trial is testing2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy ToddlersWho this might be right forMeningococcal MeningitisMeaslesMumps+2 more Sanofi Pasteur, a Sanofi Company 1,128
Large-scale testing (Phase 3)Not Yet RecruitingNCT07406360What this trial is testingA Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of AgeWho this might be right forMeasles GlaxoSmithKline 1,209
Testing effectiveness (Phase 2)Ended earlyNCT00258726What this trial is testingImmune Responses to Two Dose Varivax +/- MMR-IIWho this might be right forMeaslesMumpsRubella+1 more National Institute of Allergy and Infectious Diseases (NIAID) 105
Not applicableUnknownNCT05154097What this trial is testingImmunity Duration Study Eight Years After Vaccination of Children 12 to 23 Months With the Triple Viral Vaccine (Measles, Mumps and Rubella)Who this might be right forMeasles Vaccine The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 190
Not applicableStudy completedNCT04646239What this trial is testingBiomarkers of Trained Immunity Following MMR VaccinationWho this might be right forCovid19 Washington University School of Medicine 96
Post-approval studies (Phase 4)Looking for participantsNCT05758532What this trial is testingNon-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in ChildrenWho this might be right forRespiratory Tract InfectionsInfectionsAllergy+1 more Laure Pittet, MD-PhD 500
Large-scale testing (Phase 3)Study completedNCT00871117What this trial is testingImmunogenicity and Safety of Kinrix + (Measles Mumps Rubella) MMR Vaccine With and Without Varicella Vaccine in Healthy Children 4-6 YearsWho this might be right forTetanusAcellular PertussisDiphtheria GlaxoSmithKline 478
Testing effectiveness (Phase 2)Study completedNCT00986232What this trial is testingProQuad Dose Selection Study (V221-011)(COMPLETED)Who this might be right forMeaslesMumpsRubella+1 more Merck Sharp & Dohme LLC 1,551
Post-approval studies (Phase 4)Study completedNCT00731965What this trial is testingSafety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic ArthritisWho this might be right forArthritis, Juvenile Rheumatoid N.M. Wulffraat 140
Large-scale testing (Phase 3)Ended earlyNCT00839917What this trial is testingProQuad™ in Healthy Children in Korea (V221-023)Who this might be right forMeaslesMumpsRubella+1 more Merck Sharp & Dohme LLC 30
Large-scale testing (Phase 3)Study completedNCT00192491What this trial is testingTrial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy ChildrenWho this might be right forInfluenza MedImmune LLC 1,200
Large-scale testing (Phase 3)Looking for participantsNCT06855160What this trial is testingA Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of AgeWho this might be right forChickenpox GlaxoSmithKline 900
Large-scale testing (Phase 3)Study completedNCT00109343What this trial is testingV221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019)Who this might be right forMeaslesMumpsRubella+1 more Merck Sharp & Dohme LLC 1,027
Large-scale testing (Phase 3)Study completedNCT00483574What this trial is testingStudy of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy ToddlersWho this might be right forMeningococcal MeningitisMeaslesMumps+2 more Sanofi Pasteur, a Sanofi Company 1,378
Testing effectiveness (Phase 2)Study completedNCT00109278What this trial is testingA Measles, Mumps, and Rubella Investigational Vaccine Trial (V205C-010)(COMPLETED)Who this might be right forMeasles Merck Sharp & Dohme LLC 1,100
Post-approval studies (Phase 4)Study completedNCT05161845What this trial is testingClinical Trial of Measles, Mumps and Rubella Combined Vaccine, LiveWho this might be right forImmunotoxicityVaccine Shanghai Institute Of Biological Products 1,068
Large-scale testing (Phase 3)Study completedNCT00406211What this trial is testingLong-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined VaccineWho this might be right forRubellaVaricellaMumps+1 more GlaxoSmithKline 398
Not applicableStudy completedNCT00962819What this trial is testingMeasles, Mumps, and Rubella (MMR) Immunity in College StudentsWho this might be right forMeaslesMumpsRubella Sri Edupuganti, MD MPH 74